A fully liquid diphtheria–tetanus–five component acellular pertussis–inactivated poliomyelitis–Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants

This publication has 14 references indexed in Scilit:

• Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003
  CMAJ : Canadian Medical Association Journal, 2005
• Decrease in Hospital Admissions for Febrile Seizures and Reports of Hypotonic-Hyporesponsive Episodes Presenting to Hospital Emergency Departments Since Switching to Acellular Pertussis Vaccine in Canada: A Report From IMPACT
  Pediatrics, 2003
• Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis
  The Lancet, 1999
• An Evaluation of the Safety and Immunogenicity of a Five-Component Acellular Pertussis, Diphtheria, and Tetanus Toxoid Vaccine (DTaP) When Combined With aHaemophilus influenzaeType b-Tetanus Toxoid Conjugate Vaccine (PRP-T) in Taiwanese Infants
  Pediatrics, 1999
• Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine
  The Lancet, 1997
• Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine
  The Lancet, 1996
• A Controlled Trial of a Two-Component Acellular, a Five-Component Acellular, and a Whole-Cell Pertussis Vaccine
  New England Journal of Medicine, 1996
• The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae type b
  The Journal of Infectious Diseases, 1984
• The Protective Level of Serum Antibodies to the Capsular Polysaccharide of Haemophilus influenzae Type b
  The Journal of Infectious Diseases, 1983
• A Quantitative Immunochemical Measure of thePrimary Interaction Between I*BSA and Antibody
  The Journal of Infectious Diseases, 1958